Clinical Pharmacology of Antianginal Drugs

  • Ulrich Abshagen

Part of the Handbook of Experimental Pharmacology book series (HEP, volume 76)

Table of contents

  1. Front Matter
    Pages I-XVI
  2. General Principles

    1. Front Matter
      Pages 1-1
    2. W. Schaper, J. Schaper, H. M. Hoffmeister
      Pages 47-96
  3. Test Methods

    1. Front Matter
      Pages 117-117
    2. P. J. Oldershaw, D. G. Gibson
      Pages 153-172
    3. I. C. Roddie, W. F. M. Wallace
      Pages 173-196
    4. D. Redwood
      Pages 197-212
    5. W. E. Adam, M. Stauch
      Pages 213-237
  4. Types of Antianginal Drugs

    1. Front Matter
      Pages 285-285
    2. U. Abshagen
      Pages 287-364
    3. J. Scholtholt
      Pages 365-383
    4. B. N. C. Prichard
      Pages 385-458
    5. P. G. Hugenholtz
      Pages 459-538
  5. Back Matter
    Pages 539-552

About this book

Introduction

When I was asked some years ago by the editors of the Handbook of Experimental Pharmacology to edit a new volume on Antianginal Drugs, I agreed on the condition that, in accordance with my scientific background, primary emphasis be given to clinical pharmacology and therapeutics. It soon turned out that, due to rapid developments in this field, nothing of the previous volume on Antianginal Drugs by Charlier (Vol. 31, 1971) could be retained apart from its basic idea of devoting considerable space to methodology. Since editors must operate within certain limits, I had to abstain from dealing with acute myocardial infarction in detail despite the well-known overlap between unstable angina, the preinfarction syndrome, and acute myocardial infarction. It was only possible for acute myocardial infarction and the concept of reduction of infarct size to be briefly discussed within the chapter on pathophysiology of acute coronary insufficiency. The chapter on invasive methods provided an opportunity to touch on new approaches to early intervention in acute myocardial infarction. Here, intracoronary streptokinase therapy and PTCA are considered, again with attention to the overlap between mechanical and pharmacological interventions.

Keywords

Drugs PTCA pathophysiology pharmacology physiology research

Editors and affiliations

  • Ulrich Abshagen
    • 1
  1. 1.Boehringer Mannheim GmbHMannheim 31Germany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-69524-7
  • Copyright Information Springer-Verlag Berlin Heidelberg 1985
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-69526-1
  • Online ISBN 978-3-642-69524-7
  • Series Print ISSN 0171-2004
  • Series Online ISSN 1865-0325
  • About this book
Industry Sectors
Chemical Manufacturing
Biotechnology
Consumer Packaged Goods
Pharma